OM vs. KRMD, TLSI, INFU, STIM, SGHT, ECOR, ZJYL, LNSR, PDEX, and TELA
Should you be buying Outset Medical stock or one of its competitors? The main competitors of Outset Medical include KORU Medical Systems (KRMD), TriSalus Life Sciences (TLSI), InfuSystem (INFU), Neuronetics (STIM), Sight Sciences (SGHT), electroCore (ECOR), Jin Medical International (ZJYL), LENSAR (LNSR), Pro-Dex (PDEX), and TELA Bio (TELA). These companies are all part of the "medical equipment" industry.
Outset Medical vs.
KORU Medical Systems (NASDAQ:KRMD) and Outset Medical (NASDAQ:OM) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, earnings, risk, profitability, analyst recommendations, institutional ownership, community ranking, media sentiment and dividends.
KORU Medical Systems has higher earnings, but lower revenue than Outset Medical. KORU Medical Systems is trading at a lower price-to-earnings ratio than Outset Medical, indicating that it is currently the more affordable of the two stocks.
KORU Medical Systems presently has a consensus target price of $4.70, indicating a potential upside of 45.96%. Outset Medical has a consensus target price of $4.50, indicating a potential upside of 521.55%. Given Outset Medical's higher possible upside, analysts plainly believe Outset Medical is more favorable than KORU Medical Systems.
KORU Medical Systems has a beta of 0.74, suggesting that its stock price is 26% less volatile than the S&P 500. Comparatively, Outset Medical has a beta of 2.01, suggesting that its stock price is 101% more volatile than the S&P 500.
In the previous week, KORU Medical Systems had 3 more articles in the media than Outset Medical. MarketBeat recorded 3 mentions for KORU Medical Systems and 0 mentions for Outset Medical. Outset Medical's average media sentiment score of 0.63 beat KORU Medical Systems' score of 0.47 indicating that Outset Medical is being referred to more favorably in the news media.
58.6% of KORU Medical Systems shares are held by institutional investors. 21.7% of KORU Medical Systems shares are held by insiders. Comparatively, 4.1% of Outset Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
KORU Medical Systems received 20 more outperform votes than Outset Medical when rated by MarketBeat users. Likewise, 63.77% of users gave KORU Medical Systems an outperform vote while only 38.71% of users gave Outset Medical an outperform vote.
KORU Medical Systems has a net margin of -37.42% compared to Outset Medical's net margin of -112.57%. KORU Medical Systems' return on equity of -24.60% beat Outset Medical's return on equity.
Summary
KORU Medical Systems beats Outset Medical on 13 of the 18 factors compared between the two stocks.
Get Outset Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for OM and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Outset Medical Competitors List
Related Companies and Tools
This page (NASDAQ:OM) was last updated on 3/6/2025 by MarketBeat.com Staff